Skip to main content
Canadian Medical Association Journal logoLink to Canadian Medical Association Journal
. 1963 Oct 12;89(15):755–761.

Serum Lactic Dehydrogenase, Leucine Aminopeptidase and 5-Nucleotidase Activity

Observations in Patients with Carcinoma of the Pancreas and Hepatobiliary Disease

Charles Bardawill, Catherine Chang
PMCID: PMC1922012  PMID: 14060166

Abstract

Serum lactic dehydrogenase, leucine aminopeptidase, 5-nucleotidase and alkaline phosphatase activities were investigated in a number of diseases involving the hepatobiliary system.

Leucine aminopeptidase was found to be a sensitive indicator of biliary obstruction, serum 5-nucleotidase slightly less sensitive, and alkaline phosphatase appreciably less sensitive. Leucine aminopeptidase and 5-nucleotidase activities were often increased by malignant infiltration of the liver and primary hepatic disease even in the absence of jaundice.

Serum lactic dehydrogenase was frequently increased in primary hepatic disease and malignant disorders but was not apparently affected by bile duct obstruction per se. Thirty-five of 45 patients with proved malignancy had increased lactic dehydrogenase levels.

The highest leucine aminopeptidase levels were encountered in carcinoma of the head of the pancreas. The frequent increase in both serum lactic dehydrogenase and leucine aminopeptidase activities in patients with carcinoma of the head of the pancreas suggests that these combined estimations are useful laboratory procedures in the diagnosis of malignant extrahepatic obstruction.

Full text

PDF
755

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. GOLDBARG J. A., RUTENBURG A. M. The colorimetric determination of leucine aminopeptidase in urine and serum of normal subjects and patients with cancer and other diseases. Cancer. 1958 Mar-Apr;11(2):283–291. doi: 10.1002/1097-0142(195803/04)11:2<283::aid-cncr2820110209>3.0.co;2-8. [DOI] [PubMed] [Google Scholar]
  2. MONIS B., NACHLAS M. M., SELIGMAN A. M. Study of leucine aminopeptidase in neoplastic and inflammatory tissues with a new histochemical method. Cancer. 1959 May-Jun;12(3):601–608. doi: 10.1002/1097-0142(195905/06)12:3<601::aid-cncr2820120320>3.0.co;2-c. [DOI] [PubMed] [Google Scholar]
  3. MOORE A. E., WROBLEWSKI F. Lactic dehydrogenase production in tissue culture of normal, transformed, and malignant human cell lines. Proc Soc Exp Biol Med. 1958 Aug-Sep;98(4):782–786. doi: 10.3181/00379727-98-24185. [DOI] [PubMed] [Google Scholar]
  4. RUTENBURG A. M., GOLDBARG J. A., PINEDA E. P. Leucine aminopeptidase activity; observations in patients with cancer of the pancreas and other diseases. N Engl J Med. 1958 Sep 4;259(10):469–472. doi: 10.1056/NEJM195809042591003. [DOI] [PubMed] [Google Scholar]
  5. WROBLEWSKI F. The significance of alterations in lactic dehydrogenase activity of body fluids in the diagnosis of malignant tumors. Cancer. 1959 Jan-Feb;12(1):27–39. doi: 10.1002/1097-0142(195901/02)12:1<27::aid-cncr2820120108>3.0.co;2-5. [DOI] [PubMed] [Google Scholar]

Articles from Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES